Cleared Traditional

K173898 - MicroPort Orthopedics Total Hip Systems MR Labeling

K173898 is an FDA 510(k) clearance for MicroPort Orthopedics Total Hip Systems..., manufactured by Microport Orthopedics Inc. (Mpo). The device is a Class 2 Orthopedic device with product code LZO cleared through the Traditional 510(k) pathway after a 272-day FDA review.

K173898 · Microport Orthopedics Inc. (Mpo) · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2018
Decision
272d
Days
Class 2
Risk

K173898 is an FDA 510(k) clearance for the MicroPort Orthopedics Total Hip Systems MR Labeling. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Microport Orthopedics Inc. (Mpo) (Arlington, US). The FDA issued a Cleared decision on September 20, 2018 after a review of 272 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Microport Orthopedics Inc. (Mpo) devices

FDA 510(k) Submission Details - K173898

510(k) Number K173898 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 2017
Decision Date September 20, 2018
Days to Decision 272 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
150d slower than avg
Panel avg: 122d · This submission: 272d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LZO Device Classification - Class 2, Special Controls

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 508
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K173898.
Exactech Alteon Highly Polished Femoral Stem
K182462 · Exactech, Inc. · Nov 2018
Quadra P
K181254 · Medacta International S.A. · Oct 2018
DePuy Corail AMT Hip Prosthesis
K173960 · Depuy France S.A.S. · Sep 2018
Prime E-CLASS XLPE Liner
K181598 · Microport Orthopedics, Inc. · Sep 2018
Corin Optimized Positioning System (OPS) Femoral
K181061 · Corin USA · Sep 2018
Exactech Alteon Monobloc Revision Stem
K181532 · Exactech, Inc. · Sep 2018